Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vasso Apostolopoulos

Showing results (51-60 of 382) with videos related to

Pageof 39
Sort By:
The Lancet. Respiratory Medicine|August 20, 2022
Tomato flu outbreak in IndiaVivek P Chavda, Kaushika Patel, Vasso Apostolopoulos
Cells|November 27, 2024
Inflammation: The Cause of All DiseasesVivek P Chavda, Jack Feehan, Vasso Apostolopoulos
Molecular Pharmaceutics|January 19, 2007
Receptor-mediated delivery of antigens to dendritic cells: anticancer applicationsOwen Proudfoot, Vasso Apostolopoulos, Geoffrey A Pietersz
Expert Review of Vaccines|April 26, 2021
The emergence of new strains of SARS-CoV-2. What does it mean for COVID-19 vaccines?Md Kamal Hossain, Majid Hassanzadeganroudsari, Vasso Apostolopoulos
Expert Review of Vaccines|November 30, 2020
Why METH users are at high risk of fatality due to COVID-19 infection?Md Kamal Hossain, Majid Hassanzadeganroudsari, Vasso Apostolopoulos
Cellular and Molecular Life Sciences : CMLS|August 22, 2015
MUC1 (CD227): a multi-tasked moleculeVasso Apostolopoulos, Lily Stojanovska, Sharron E Gargosky
Immunology|February 16, 2006
Penetratin tandemly linked to a CTL peptide induces anti-tumour T-cell responses via a cross-presentation pathwayDodie S Pouniotis, Vasso Apostolopoulos, Geoffrey A Pietersz
Expert Opinion on Biological Therapy|November 8, 2008
The good, the bad and the ugly: how altered peptide ligands modulate immunityMaria Katsara, Gabriela Minigo, Magdalena Plebanski, et al.
Acta Biochimica Et Biophysica Sinica|December 14, 2018
Progression of carotid artery disease could stratify a risk of coronary artery disease patients with type 2 diabetesMarijan Bosevski, Pece Nikolovski, Lily Stojanovska, et al.
Anticancer Research|July 31, 2014
Tumor regression by CD4 T-cells primed with dendritic/tumor fusion cell vaccinesShigeo Koido, Yutaka Enomoto, Vasso Apostolopoulos, et al.
Pageof 39

Showing results (51-60 of 382) with videos related to

Sort By:
Pageof 39
The Lancet. Respiratory Medicine|August 20, 2022
Tomato flu outbreak in IndiaVivek P Chavda, Kaushika Patel, Vasso Apostolopoulos
Cells|November 27, 2024
Inflammation: The Cause of All DiseasesVivek P Chavda, Jack Feehan, Vasso Apostolopoulos
Molecular Pharmaceutics|January 19, 2007
Receptor-mediated delivery of antigens to dendritic cells: anticancer applicationsOwen Proudfoot, Vasso Apostolopoulos, Geoffrey A Pietersz
Expert Review of Vaccines|April 26, 2021
The emergence of new strains of SARS-CoV-2. What does it mean for COVID-19 vaccines?Md Kamal Hossain, Majid Hassanzadeganroudsari, Vasso Apostolopoulos
Expert Review of Vaccines|November 30, 2020
Why METH users are at high risk of fatality due to COVID-19 infection?Md Kamal Hossain, Majid Hassanzadeganroudsari, Vasso Apostolopoulos
Cellular and Molecular Life Sciences : CMLS|August 22, 2015
MUC1 (CD227): a multi-tasked moleculeVasso Apostolopoulos, Lily Stojanovska, Sharron E Gargosky
Immunology|February 16, 2006
Penetratin tandemly linked to a CTL peptide induces anti-tumour T-cell responses via a cross-presentation pathwayDodie S Pouniotis, Vasso Apostolopoulos, Geoffrey A Pietersz
Expert Opinion on Biological Therapy|November 8, 2008
The good, the bad and the ugly: how altered peptide ligands modulate immunityMaria Katsara, Gabriela Minigo, Magdalena Plebanski, et al.
Acta Biochimica Et Biophysica Sinica|December 14, 2018
Progression of carotid artery disease could stratify a risk of coronary artery disease patients with type 2 diabetesMarijan Bosevski, Pece Nikolovski, Lily Stojanovska, et al.
Anticancer Research|July 31, 2014
Tumor regression by CD4 T-cells primed with dendritic/tumor fusion cell vaccinesShigeo Koido, Yutaka Enomoto, Vasso Apostolopoulos, et al.
Pageof 39